< Back

Genetics and Parkinson's

Dr Stephen Mullin, lecturer at Plymouth University, is interviewed about genetics and Parkinson’s.

In recent years it has become clear that genetics plays a key role in the development of Parkinson’s. By understanding genetic pathways, the hope is that a novel drug to prevent or slow down Parkinson’s development can be produced. One of the most common genes implicated in Parkinson’s is glucocerebrosidase (GBA). About 10% of people with Parkinson’s in the UK carry a mutation in this gene.

Previous
Next